View in EDS HTML Full Text PDF Full Text

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.

Saved in:

Bibliographic Details
Title:	Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.
Authors:	Shimazu, Yutaka¹ (AUTHOR), Kanda, Junya¹ (AUTHOR) jkanda16@kuhp.kyoto-u.ac.jp, Kosugi, Satoru² (AUTHOR), Ito, Tomoki³ (AUTHOR), Kaneko, Hitomi⁴ (AUTHOR), Imada, Kazunori⁴ (AUTHOR), Shimura, Yuji⁵ (AUTHOR), Fuchida, Shin-ichi⁶ (AUTHOR), Fukushima, Kentaro⁷ (AUTHOR), Tanaka, Hirokazu⁸ (AUTHOR), Yoshihara, Satoshi⁹ (AUTHOR), Ohta, Kensuke¹⁰ (AUTHOR), Uoshima, Nobuhiko¹¹ (AUTHOR), Yagi, Hideo¹² (AUTHOR), Shibayama, Hirohiko¹³ (AUTHOR), Yamamura, Ryosuke¹⁴ (AUTHOR), Tanaka, Yasuhiro¹⁵ (AUTHOR), Uchiyama, Hitoji¹⁶ (AUTHOR), Onda, Yoshiyuki¹⁷ (AUTHOR), Adachi, Yoko¹⁸ (AUTHOR)
Source:	Scientific Reports. 3/29/2023, Vol. 13 Issue 1, p1-12. 12p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!